COMPUTED DESCRIPTORS
| Molecular Weight | 359.5 g/mol |
|---|---|
| XLogP3 | 5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 359.06498575 g/mol |
| Monoisotopic Mass | 359.06498575 g/mol |
| Topological Polar Surface Area | 113 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 444 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Tazasubrate is an agent with with antilipidemic activity. In animal models tazasubrate caused a reduction of serum cholesterol consistent with accelerated plasma cholesterol turnover.
